Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT05012254Phase 2Active Not Recruiting
Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases
Brain Metastases, AdultLung CancerNon Small Cell Lung Cancer
PrincipalinvestigatorStart date: 2021-11-18
NCT05009030Completed
Anti-SARS-COV2 Vaccination Study in Lung Cancer Patients
Covid19Lung Cancer
StudychairStart date: 2021-05-06

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Fundación GECP Investigator

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT05012254Phase 2PrincipalInvestigator

Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases

Brain Metastases, AdultLung CancerNon Small Cell Lung Cancer
Active Not Recruiting
NCT05009030StudyChair

Anti-SARS-COV2 Vaccination Study in Lung Cancer Patients

Covid19Lung Cancer
Completed

All 2 trials loaded